Gary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor
Advertisement
Articles by Gary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK
2
When Foreign Investments in Pharma and Biotech Become a National Security Concern
3
Addressing Launch Drift to Optimize Product Launches
4
What FDA's Peptide Decision Means for the Industry
5